Table 1.
Baseline characteristics of the population.
| Parameter |
All patients (n = 152) |
p-value | |
|---|---|---|---|
| CVD (n = 42) | Non CVD (n = 110) | ||
| Male sex, n (%) | 28 (66.7) | 58 (52.7) | 0.14 |
| Age, y.o * | 68 (58–82) | 71 (54–80) | 0.98 |
| Obesity n (%) | 4 (9.5) | 18 (16.4) | 0.44 |
| HTN, n (%) | 18 (42.9) | 64 (58.2) | 0.10 |
| HTN new diagnosis, n (%) | 4 (9.5) | 6 (5.5) | 0.46 |
| Diabetes, n (%) | 12 (28.6) | 12 (10.9) | 0.01 |
| Dyslipidemia, n (%) | 10 (23.8) | 24 (21.8) | 0.83 |
| At least 1 CRF-X, n (%) | 28 (66.7) | 80 (72.7) | 0.55 |
| CAD, n (%) | 10 (23.8) | 10 (9.1) | 0.02 |
| CABG, n (%) | 2 (4.8) | 2 (1.8) | 0.30 |
| PCI, n (%) | 6 (14.3) | 6 (5.5) | 0.09 |
| AF, n (%) | 6 (14.3) | 10 (9.1) | 0.38 |
| CRF, n (%) | 8 (19.04) | 12 (10.9) | 0.19 |
| HF, n (%) | 6 (14.2) | 6 (5.5) | 0.09 |
| Valvulopathy, n (%) | 8 (19.04) | 6 (5.5) | 0.02 |
| COPD, n (%) | 4 (9.5) | 10 (9.1) | 1 |
| Asthma, n (%) | 2 (4.8) | 2 (1.8) | 0.28 |
| Cancer, n (%) | 8 (19.0) | 18 (16.4) | 0.81 |
| Chemotherapy, n (%) | 6 (14.3) | 12 (10.9) | 0.58 |
| Radiotherapy, n (%) | 2 (4.8) | 4 (3.6) | 0.67 |
Unless specified, values are number of patients (%). * median (interquartile range).
AF: atrial fibrillation, CABG: coronary artery bypass grafting, CAD: coronary artery disease, CVD: cardiac disease, COPD: chronic obstructive pulmonary disease, CRF: chronic renal failure, CRF-X: classical risk factors, HF: heart failure, HTN: hypertension, PCI: percutaneous coronary intervention.